Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
24.48
+4.80 (24.39%)
At close: Jan 5, 2026, 4:00 PM EST
24.48
0.00 (0.00%)
After-hours: Jan 5, 2026, 7:42 PM EST
Burning Rock Biotech Market Cap
Burning Rock Biotech has a market cap or net worth of $263.57 million as of January 5, 2026. Its market cap has increased by 282.89% in one year.
Market Cap
263.57M
Enterprise Value
203.05M
1-Year Change
282.89%
Ranking
Category
Stock Price
$24.48
Market Cap Chart
Since June 12, 2020, Burning Rock Biotech's market cap has decreased from $2.51B to $263.57M, a decrease of -89.49%. That is a compound annual growth rate of -33.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 211.89M | -2.33% |
| Dec 31, 2025 | 216.95M | 213.30% |
| Dec 31, 2024 | 69.25M | -29.38% |
| Dec 29, 2023 | 98.06M | -58.57% |
| Dec 30, 2022 | 236.67M | -76.25% |
| Dec 31, 2021 | 996.35M | -58.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| UnitedHealth Group | 304.72B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |